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The lymphatic vasculature has been regarded as a passive conduit for interstitial fluid and responsible for the
absorption of macromolecules such as proteins or lipids and transport of nutrients from food. However, emerging
data show that the lymphatic vasculature system plays an important role in immune modulation. One of its major
roles is to coordinate antigen transport and immune-cell trafficking from peripheral tissues to secondary lymphoid
organs, lymph nodes. This perspective was recently updated with the notion that the interaction between lymphatic
endothelial cells and leukocytes controls the immune-cell migration and immune responses by regulating lymphatic
flow and various secreted molecules such as chemokines and cytokines. In this review, we introduce the lymphatic
vasculature networks and genetic transgenic models for research on the lymphatic vasculature system. Next, we
discuss the contribution of lymphatic endothelial cells to the control of immune-cell trafficking and to maintenance
of peripheral tolerance. Finally, the physiological roles and features of the lymphatic vasculature system are further
discussed regarding inflammation-induced lymphangiogenesis in a pathological condition, especially in mucosal
tissues such as the gastrointestinal tract and respiratory tract.
[Immune Network 2017;17(1):68-76]
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INTRODUCTION
The lymphatic vasculature system is important for at
least three functions; first, it controls the absorbance
of nutrients including proteins and lipids from blood
vasculature into peripheral tissues. Moreover, other
small molecules such as cytokines and chemokines of
interstitial fluids are transported through the lymphatic
vessels. Second, lymphatic vessels are used as a route
of immune cell trafficking from peripheral tissues into
lymph nodes. Lymphocytes and dendritic cells that have
encountered foreign antigens can access the lymphatic

capillaries dependent on chemokine gradients (1,2).
Lastly, the lymphatic vasculature system maintains the
homeostasis of tissue fluid by regulating lymph transport.
The lymph fluid drains into the thoracic lymphatic duct,
then gets back into blood circulation (3). This lymphatic
transport is tightly regulated by the osmotic gradients and
fluid barrier filtration from cytokines, chemokine, and
other macromolecules (2). Accordingly, individuals with
abnormal lymph circulation or surgery to remove a lymph
node can develop lymphedema with impaired immune
responses. In this review, we demonstrate the general
functions of the lymphatic vasculature system and then
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discuss studies from the perspective that the lymphatic
system is closely linked with the pathophysiology of
inflammatory conditions and can control them. Especially,
we focus on elucidation of how specialized lymphatic
vasculature coordinates multiple physiological roles,
how lymphatic vessels regulate immune cell trafficking,
and how lymphatic vessels themselves respond to inflammation.

lymPhaTICs IN The CIRCUlaTORy sysTem
In our body, the vascular circulatory system consists of
blood and lymphatic vessels, both of which are lined by
endothelial cells. Lymphatic vasculature is composed of a
branched network of capillaries and collecting lymphatic
vessels. Unlike blood vasculature, lymphatic capillaries
are blind-ended and lack pericytes. As an open system,
the ubiquitous network of lymphatic capillaries (10 to
80 mm in diameter) and vessels transport interstitial fluid
from the arterial ends of blood vessels back into the main
circulatory system. Interstitial fluid enters the lymphatic
system through single-layered lymph capillaries. The
discontinuous basement membrane and weak cell-tocell attachments make the lymphatic capillaries highly
permeable, thereby facilitating uptake of proteins
including nutrients, viruses, and other large solutes, which
in general have very low diffusivity (4). Unidirectional
fluid flow from the capillaries toward the lymph nodes is
regulated by lymphatic valves, which inhibit its backflow.
The individual capillaries merge to form large lymphatic
collecting vessels. The lymphatic collecting vessels are
segmented into regions called lymphangions that are
interconnected by semi-lunar valves that prevent backflow
of the lymph through the lumen of the lymphangions.
Synergistic functioning of these two types of valves
coupled with rhythmic contraction and relaxation of the
smooth muscular layer of the lymphangions produces a
motion and forces lymph from one lymphangion to the
next. The lymphangions finally merge into afferent lymph
vessels, which subsequently drain into the subcapsular
sinus of various lymph nodes located throughout the body.
Recent studies suggest that the major source of lymphatic endothelial cells during development in mammals is
generated through trans-differentiation from embryonic
veins (5). During differentiation into lymphatic
endothelial cells (LECs), prospero-related homeodomain
transcription factor (Prox1) is essential for lymphaticendothelium-specific programming. Prox1 downregulates
blood markers and promotes expression of vascular
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endothelial growth factor receptor (VEGFR)-3, which is
important for LEC survival, migration, and proliferation.
LECs then start to bud by following the gradient of a
VEGFR-3 ligand, VEGFC (6). As a selective marker
for lymph capillary endothelial cells, lymphatic vessel
endothelium hyaluronan receptor (LYVE-1) has been
utilized commonly to study the lymph vessel network. In
addition, to visualize the lymphatic vessels in vivo , Prox1fluorescently-labeled transgenic animals that expresses
GFP or tdTomato driven by the promoter of Prox1, a
master regulator in lymphatic development, have been
broadly used. Adult lymphatic vessels could be easily
detected in peripheral tissue such as the trachea, skin, ear,
intestine, and diaphragm (7). Such identification, in recent
decades, of several key regulators and markers specific to
LECs has accelerated findings that LECs actively interact
with other cells.

lymPhaTIC vessels fROm PeRIPheRal TIssUes
TO lymPh NODes
Together with macrophages and monocytes, dendritic
cells (DCs) belong to the mononuclear phagocyte
system. Both macrophages and DCs are in close contact
with LECs for adaptive immunity and tolerance. Early
reports showed that lymph-borne antigens arrive in
lymph nodes only a few minutes after subcutaneous
injection (8). As a secondary lymphoid organ, a lymph
node is the main place to activate an immune response as
well as the terminal end of the lymphatic system before
the lymph fluid is drained into the circulatory system.
Before draining into the vein of the circulatory system,
the lymph fluid is screened for foreign antigens in the
lymph node through the efferent lymphatic vessels.
Strategically positioned along lymphatic vessels of the
subcapsular sinus, lymph node-resident macrophages
play a key role in filter stations, preventing systemic
pathogen dissemination (9). Furthermore, the lymphatic
vasculature system supports immune cell migration as
well as lymph fluid circulation from a tissue to lymph
nodes. Lymphatic capillaries and collecting vessels
require differential several steps to move DCs into a
lymph node (1). By highly expressing CCL19 and CCL21,
lymphatic capillaries attract DCs expressing CC-chemokine receptor 7 (CCR7). In addition to chemokine gradient-dependent migration, it was proposed that their
migration is dependent on amoeboid movement rather
than integrin-dependent movement in a steady state (2,10).
In a pathological condition, dendritic cells are activated
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by pathogen-associated molecular patterns (PAMPs)
such as Toll-like receptors (TLRs), and their movement
depends on integrins such as ICAM-1 and VCAM-1.
Once DCs enter the lymphatic capillaries from peripheral
tissues, DCs crawl onto LECs toward the lymphatic
collecting vessels by taking advantage of binding CCR7
to its ligands CCL19 and CCL21. CCL21 deficiency
completely impairs the DC migration, suggesting that
intra-lymphatic migration of DCs is dependent on the
CCL21 chemotactic gradient (11). Upon arrival into the
lymphatic collecting vessels, lymphatic fluid force leads
passive transport of DCs into the subcapsular sinus of a
lymph node. In lymphatic collecting vessels, the direction
and rate of lymphatic flow are regulated by lymphatic
valves and lymphatic muscle. Lymphatic muscle surrounding LECs contributes to the contraction of lymphatic
collecting vessels by regulating lymph pressure (12).
In addition to the lymphatic valve and muscle, DCs
surrounding the lymphatic collecting vessels affect the
permeability of lymphatic collecting vessels by interacting
with LECs. In the absence of CCR7, the interaction
between DCs and the endothelial cells of lymphatic
collecting vessels is highly reduced because of the loss
of CCR7–CCL21 interaction (12). Lymphatic collecting
vessels show various phenotypes in CCR7-deficient mice.
First, collagen deposition is dramatically increased on the
collecting vessel wall, resulting in fibrosis. Second, the
permeability of collecting vessels is significantly elevated
in CCR7-deficient mice, implying that CCR7 + DCs
control lymphatic permeability. Lastly, the removal of a

lymph-derived tracer is altered in CCR7-deficient mice,
suggesting that lymphatic transport is associated with DCs.
In addition to the regulation of lymphatic permeability,
lymphatic collecting vessels seem to orchestrate a local
immune response by adipose tissue myeloid cells including DCs (13). Injected into skin, fluorescent antigen
tracers are delivered to CD11c+ MHCII+ DCs in adipose
tissue through the collecting lymphatic vessels, suggesting
that these DCs sample lymph-borne antigens during local
inflammation and T-cell infiltration (Fig. 1). In addition,
CD11b+ Gr1+ myeloid cells suppress the contraction of
lymphatic collecting vessels in an inflammatory condition
(14). Overall, lymphatic flow in lymphatic collecting
vessels is tightly regulated by spatially distinct LECs
and by the cross-talk between LECs and tissue-resident
DCs. Nonetheless, further research is necessary on the
molecular mechanism explaining how peripheral tissue
resident DCs regulate LECs.

The ROle Of lymPhaTICs IN The RegUlaTION Of
TOleRaNCe
As discussed above, the lymphatic vasculature provides
routes for DC and lymphocyte migration into and out of a
lymph node. LECs control these processes by expression
of chemokines and adhesion molecules. LECs also can
express immunosuppressive factors such as TGF- b ,
indoleamine-2,3-dioxygenase, and nitric oxide to maintain
peripheral tolerance to self-antigens in lymph (15,16)

Figure 1. Schematic models of lymphatic flow. (A) Activated DCs can enter the lymphatic capillaries in a CCR7-dependent but integrin-independent
manner. Other molecules such as proteins and lipids can be absorbed in lymphatic capillaries. (B) In capillaries, lymphatic endothelial cells drive
DCs toward lymphatic collecting vessels by forming chemokine gradients. (C) Once DCs enter the collecting vessels, the interaction of adipose
myeloid cells and collecting endothelial cells controls lymphatic flow, which facilitates passive transport of DCs into a lymph node.
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In this regard, LECs participate in the immune response
by releasing an appropriate chemokine and cytokines in
response to environmental changes in peripheral tissues.
Emerging studies demonstrate that lymphatic vessels
exhibit tolerogenic potential by regulating T-cell fate and
function in immunity. First, it has been shown that LECs
can directly dampen DC maturation (17), in turn reducing
their ability to activate effector T cells. Second, LECs
constitutively express and present a self-antigen on MHC
class I molecules to delete autoreactive T cells and thus
help maintain peripheral tolerance to these self-antigens
(18). LECs can drive deletional tolerance of naïve CD8
T cells without costimulatory molecules necessary to
activate effector T cells, and instead express the inhibitory
ligand PD-L1 (19). Third, it is now known that LECs
can actively scavenge exogenous lymph-borne antigens
and process them for cross-presentation on MHC class
I molecules (20,21). In summary, LECs may potentially
help to maintain tolerogenic pressure by presenting both a
scavenged and endogenous antigen.

The ROle Of lymPhaTICs IN INflammaTION
The inflammation process is accompanied by several
localized or systemic events such as vascular responses,
migration and activation of leukocytes, and systemic
inflammatory response syndrome. Additionally, lymphangiogenesis frequently occurs during inflammation. To
relieve the hostile microenvironment causing inflammation, a harmful antigen and debris should be removed
by drainage of excessive interstitial fluid through lymphatic vasculature. Upon initiation of inflammation, the
lymphatic system is activated, and both the lymphatic
vessels in peripheral tissues and inside a lymph node
expand in response to inflammation. Accumulating
evidence suggests that inflammation-associated lymphangiogenesis is not an endpoint phenotype of inflammation
but rather a type of dynamic and active reaction that can
control the inflammatory response or tissue repair (22).
Lymphatic vessels newly generated by inflammation
play a role in regulation of repair of a damaged tissue
(23) and macrophage/DC recruitment, which is critical
for pathogen clearance (24). The infiltrating monocytederived macrophages in the lymphatic vessel induce
lymphangiogenesis by secreting lymphangiogenic growth
factors (VEGF) (25). These ligands (VEGF) secreted
from infiltrated macrophages could be major mediators of
pathogen clearance and inflammation resolution through
profound expansion of lymphatic vessels, enhanced
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lymph flow, and mobilization of inflammatory cells from
the inflamed skin to the draining lymph nodes (26). Such
interactions between lymphatic vessels and immune
cells contribute to the immune system’s response to inflammatory stimuli. Consequently, the inflammationassociated lymphangiogenesis may directly influence
the degree of mucosal edema and leukocyte infiltration.
Impairment of lymphatic drainage caused by infection,
surgery, or trauma results in lymphedema with swelling of
limbs or other peripheral mucosal tissues. The associated
lymphostasis causes persistence and accumulation of
the antigen, foreign material, and immune complexes
in the interstitium, which can cause chronic localized
inflammation and fibrosis. This chronic inflammation
also attenuates lymphatic contraction, hindering lymphatic flow to the lymph node and disrupting the trafficking
of lymphocytes to the lymph node. Thus, lymphedema
cumulatively results in a region of local immune suppression (27). Accordingly, altered immunity has been reported in lymphedema, highlighting the importance of
lymphatic pathways in adaptive immune responses in
a variety of pathologies. Overall, the role of lymphatic
vessels in the modulation of the immune system in terms
of response to inflammation caused by environmental
stimulation of peripheral tissues is crucial for homeostasis.
In the detailed molecular mechanism of lymphangiogenesis, pro-lymphangiogenic signaling pathways,
among which the VEGF-C and D/VEGFR3 axis is
the best characterized, are activated by inflammatory
stimuli. Inhibition of the VEGF-C/VEGFR3 axis suppresses lymphangiogenesis and relieves the severity of
inflammatory symptoms in rheumatoid arthritis and LPSinduced acute inflammation (26). In addition, VEGF-A
either promotes lymphatic vasculature formation via
activation of VEGFR2 in repair associated lymphangiogenesis (28). However, T cells negatively regulate
lymphatic vessels through T helper 1 (Th1) or Th2
cytokines (anti-lymphangiogenic factors) (29). During
the acute stage of inflammation, the pro-lymphangiogenic
factors usually dominate, in which case, finally, lymphatic
vessels are amplified. As inflammation resolves, the antilymphangiogenic effect increases. The balance between
the pro-lymphangiogenic factors (VEGF-A, VEGF-C,
VEGF-D) and anti-lymphangiogenic factors (Th1: IFN-g,
Th2: IL-4, IL-13) produced by immune cells influences
the actual response of lymphatic vessels to inflammatory
stimuli. Accordingly, lymphatic vessels either grow or
regress. In the clinic, treatments for lymphedema include
lymphatic compression, exercise, or surgical interventions
to improve the lymph flow. Thus, these research studies
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suggest that targeting the anti-lymphangiogenic factors
alone or in conjunction with other therapeutic approaches
could be a new strategy for treating lymphedema caused
by infection or environmental stress.

TLRs and activate NF-kB by LPS and other TLR ligands
for induction of inflammatory lymphangiogenesis (32).
Therefore, LECs may have tissue-specific phenotypes and
functions depending on the tissue environment in which
they are located.

lymPhaTIC vessels IN mUCOsal TIssUes

gastrointestinal tract

Lymphatics are prevalent in mucosal tissues that come
into direct contact with the external environment. In
this context, depending on the tissue environmental
stimulation, LECs have distinct phenotypic and functional
characteristics (30). Additionally, lymphatic vessels,
which continuously transport circulating antigens, may
represent an important line of defense against pathogens.
It is striking that NF- k B activity is constitutive in
lymphatics of respiratory and gastrointestinal systems
that are in direct contact with external environment (31).
In mice with a reporter gene for NF-kB activity (kBlacZ), NF-kB is constitutively active in the lymphatic
endothelium rather than in blood vessels in the uterus,
intestine, and airways under normal conditions (31).
These observations challenge the notion that the recognition of externally stimulated PAMPs by TLRs in lymphatic vessels results in the activation of transcription
factor NF-kB as part of innate immunity. Several studies
have revealed that LECs express large amounts of various

Lymphatics in the gastrointestinal (GI) tract perform
important mucosal immune functions in acquired immunity and tolerance because the GI tract is widely
exposed to commensal bacteria. Lymphatic capillaries in
the center of intestinal villi, called lacteal, are important
for the absorption of nutrients as well as immune cell
trafficking into mesenteric lymph nodes. The intestine
contains three layers of lymphatics, including (in the
direction from the luminal surface to the serosal surface):
the lacteals in the villi, a submucosal lymphatic network,
and a lymphatic network in the smooth muscle layer (Fig.
2). The lacteals connect with the submucosal lymphatic
network at the base of the villi. A recent study revealed
that lacteal longitudinally has been surrounded by bundles
of smooth muscles and consequently are responsible
for spontaneous contractile dynamics (33). This finding
indicates that even though the lacteal is located at the end
of peripheral tissue as a capillary, the lacteal has a unique
tissue-specific lymphatic system that does not serve as a
passive conduit but as an active pump, which transports

Figure 2. The small-intestine lymphatic system. The small intestine contains two independent lymphatic networks that drain into a common network
of collecting lymphatics. The lacteals, draining individual villi, connect with a network of lymphatics within the mucosal layer to form one distinct
network (red), while the lymphatics of the mucosal muscle layer form another network (blue). Injection of tracers into these networks reveals free
flow within each network but no exchange between networks. Both networks drain into contractile collecting lymphatics (yellow) located at the
mesenteric border and outside of the intestine.
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lipids. Using conditional ablation of Lyve-1+ lacteals in
the small intestine, it was revealed that the disappearance
of lacteals gives rise to the distortion of blood capillaries
and the whole architecture of villi, which allows for a
massive invasion of intestinal pathogens without a barrier
and immune surveillance and subsequently causes severe
inflammation in the intestine (34). Likewise, intestinal
lacteals contribute to the defense system against mucosal
pathogens in the lumen.
Intestinal lymphatics are involved in a variety of disease
processes such as congenital malformations resulting in
pathological dilation of lymphatic vessels (lymphangiectasia) and inflammation with dynamic lymphatic growth
and remodeling (35). Increased lymphatics have are seen
in ulcerative colitis (UC) along with lymphangiectasia,
particularly in areas with epithelial dysplasia (36). While
lymphangiogenesis and lymphangiectasia are also found
in ileal and colonic Crohn’s disease (CD) (37), these
observations imply a more direct correlation between lymphatics and the colitis pathogenesis. These studies showing
a role of lymphatics in inflammatory bowel disease
suggest that understanding the cause and consequences
of lymphangitis could be a key to understanding Crohn’s
disease pathogenesis.
The intestinal environmental factors selectively affect
the development of the intestinal lymphatic system.
Fasting-induced adipose factor (Fiaf) also called angiopoietin-like protein 4 (Angptl4) is produced in the intestine and regulates the expression of Prox1, a transcription
factor crucial for lymphangiogenesis (38). Deletion of
the fiaf gene results in failure of blood and lymphatic
vasculature partitioning in the small intestine. This
finding emphasizes the uniqueness of the intestinal
lymphatic system related to its role as a pathway for
nutrient transport. Accumulating recent discoveries about
the intestinal lymphatic vasculature in the GI tract offer
convincing evidence that the lymphatic system in the
intestinal mucosa is affected by and directly contributes to
the pathogenesis of intestinal diseases.
Respiratory tract

In the steady state, lymphatic vessels of the respiratory
tract optimize and facilitate the entrance of immune
cells and interstitial fluid. As described above, the initial
lymphatic capillaries are discontinuous button-like
junctions, through which inflammatory cells frequently
pass. Interestingly, the airway infected with Mycoplasma
pulmonis shows growing lymphatic sprouts, which
have a continuous junctional pattern, zippers instead
of buttons (39). Such remodeling of the lymphatic
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vessels makes them less permeable and contributes
to impaired fluid clearance and mucosal edema. After
inflammation is resolved, the number of the lymphatic
sprouts is decreased, and their microstructure again
consists of buttons (40). Chronic inflammatory diseases
involving the respiration system may be accompanied
by significant structural alterations of lymphatic vessels,
which probably are irreversible changes that are resistant
to lymphatic-modulating treatments. When lymphangiogenesis is impaired, airway inflammation may lead
to bronchial lymphedema and exaggerated airflow obstruction. Impaired drainage of the edema fluid may be
expected to lead to airway wall thickening, reduced wall
compliance, and narrowing of the airway lumen. Correction of defective lymphangiogenesis may benefit
the treatment of asthma and other inflammatory airway
diseases (41). Consistent with these consequences of impaired lymphangiogenesis is the finding that blocking
of the lymphatic transport from inflamed rabbit ear
skin may exacerbate local edema and eventually lead to
necrosis (42). Thus, if lymphangiogenesis is impaired in
inflamed airways, restoration of lymphangiogenesis may
complement conventional therapies for inflammatory
airway diseases.

CONClUsIONs
The lymphatic vasculature system, which has a specialized network of structures to transport tissue fluid and
materials such as proteins and lipids to blood vasculature,
closely interacts with distinct immune cells for execution
of specific functions. For efficient flow from lymphatic
capillaries to lymph nodes, LECs interact with myeloid
cells in adipose tissue to regulate lymphatic permeability.
For an immune reaction, activated immune cells such as
DCs and memory T cells can actively or passively migrate
from the tissue to lymph nodes through lymphatic vessels.
The latter participate in the immune response by releasing
an appropriate chemokine and cytokines in response to
environmental changes in peripheral tissues. Because
lymphatic vasculature is widespread throughout the
whole body including the brain, it has been proposed that
lymphatic vasculature maintains the peripheral tolerance
in a steady state. In a pathological condition, however,
inflammation frequently induces lymphangiogenesis,
resolving inflammation by recruiting additional immune
cells. Although VEGF-C and VEGFR3 have been mainly
studied as key pro-lymphangiogenesis regulatory factors,
it is still unknown whether other factors are involved
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in a tissue-dependent manner. In particular, intestinal
lymphatic capillaries are constantly exposed to the
commensal microbiota and are important for immunecell migration as well as nutrient absorbance. Therefore,
it is necessary to conduct a molecular mechanistic study
on the interaction between the commensal microbiota
and lacteal development. Furthermore, the correlation
between the lymphatic system and immune cells can be
considered a therapeutic target in disease models such as
Crohn’s disease and ulcerative colitis in future studies.
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